Ontogenesis of CYP2C-dependent arachidonic acid metabolism in the human liver: Relationship with sudden infant death syndrome

Pediatric Research

Volumn 47, Issue 5, 2000, Pages 677-683

  Tréluyer, Jean Marc ^a   Benech, Henri ^b   Colin, Isabelle ^b   Pruvost, Alain ^b   Chéron, GÉRARD ^c   Cresteil, Thierry ^a,d  

^a INSERM   (France)

^b DSV/DRM   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; ARACHIDONIC ACID; CYTOCHROME P450 2C9; ICOSATRIENOIC ACID; SULFAPHENAZOLE; UNSPECIFIC MONOOXYGENASE;

ARACHIDONIC ACID METABOLISM; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; FETUS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEWBORN; ONTOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUDDEN INFANT DEATH SYNDROME;

EID: 0343294009     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200005000-00020     Document Type: Article

References (36)

1. Bouvier-Colle MH, Inizan J, Michel E 1989 Postneonatal mortality, sudden infant death syndrome: factors preventing the decline of infant mortality in France from 1973 to 1985. Paediatr Perinatal Epidemiol 3:250-261
2. Shannon DC, Kelly DH 1982 SIDS and near-SIDS. N Engl J Med 306:956-965
3. Grether JK, Schulman J. 1989. Sudden infant death syndrome and birth weight. J Pediatr 114:561-567
4. Cheron G, Rambaud C, Rey C, Mahut B, Canioni D, Lavaud J, Rouzioux C, Hubert P, Rudler M, Brousse N, Nezelof C 1993 Morts subites au berceau. Expérience d'un centre de référence 1986-1991 Arch Fr Pediatr 50:293-299
5. Ponsonby AL, Dwyer T, Jones ME 1992 Sudden infant death syndrome: seasonally and a biphasic model of pathogenesis. J Epidemiol Community Health 46:33-37
6. Cresteil T, Beaune P, Kremers P, Celier C, Guengerich FP, Leroux JP 1985 Immunoquantification of epoxide hydrolase and cytochrome P-450 isoenzymes in fetal and adult human liver microsomes. Eur J Biochem 151:345-350
7. Treluyer JM, Jacqz-Aigrain E, Alvarez F, Cresteil T 1991 Expression of CYP2D6 in the developing human liver. Eur J Biochem 202:583-588
8. Vieira I, Sonnier M, Cresteil T 1996 Developmental expression of CYP2E1 in the human liver: hypermethylation control of gene expression during the neonatal period. Eur J Biochem 238:476-483
9. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O, Okuda K, Neben DW 1993 The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes and nomenclature. DNA Cell Biol 12:1-51
10. Treluyer JM, Chéron G, Sonnier M, Cresteil T 1996 Sudden Infant Death Syndrome and hepatic cytochrome P450 content. Biochem Pharmacol 52:497-504
11. Beurton F, Gueret G, Horisberger M, Cheron G, Cresteil T 1999 Transcriptional activation of CYP2C, MxA and Fas in Sudden Infant Death Syndrome. Int J Mol Med 3:33-39
12. Daikh BE, Lasker JM, Raucy JL, Koop DR 1994 Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P 450:2C8 and 2C9. J Pharmacol Exp Ther 271:1427-1433
13. Rifkind AB, Lee C, Chang TKH, Waxman DJ 1995 Arachidonic acid metabolism by human cytochrome P450s 2C 8:2C9, 2E1 and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch Biochem Biophys 320:380-389
14. Rosolowsky M, Falck JR, Willerson JT, Campbell WB 1990 Synthesis of lipoxygenase and epoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries Circ Res 66:608-621
15. Pinto A, Abraham NG, Mullane KM 1986 Cytochrome P450-dependent monooxygenase activity and endothelial-dependent relaxations induced by arachidonic acid. J Pharmacol Exp Ther 236:445-451
16. Zeldin DC, Wei S, Kalck JR, Hammock BD, Snapper JR, Capdevila JH 1995 Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis. Arch Biochem Biophys 316:443-451
17. Laniado-Schwartzman M, Davis KL, McGiff JC, Levere RD, Abraham ND 1988 Purification and characterization of cytochrome P450-dependent arachidonic acid epoxygenase from human liver. J Biol Chem 263:2536-2542
18. Zeldin DC, Foley J, Ma J, Boyle JE, Pascual, Moomaw CR, Tomer KB, Steenbergen C, Wu S 1996 CYP2J subfamily P450s in the lung: expression, localization and potential functional significance. Mol Pharmacol 50:1111-1117
19. Zeldin DC, Foley J, Goldsworthy SM, Cook ME, Boyle JE, Ma J, Moomaw CR, Tomer KB, Steenbergen C, Wu S 1997 CYP2J subfamily cytochrome P450s in the gastrointestinal tract: expression, localization and potential functional significance. Mol Pharmacol 51:931-943
20. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
21. Greim H 1970 Synthesesteigerung und abbauhemmung bei der vermchrung der mikrosomalen cytochrome P450 und b5 durch phenobarbital. Arch Pharmacol 266:261-275
22. Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685
23. Wang P, Beaune P, Kaminsky LS, Dannan GA, Kadlubar FF, Larrey D, Guengerich FP 1983 Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. Biochemistry (USA) 22:5375-5383
24. Knodell RG, Hall SD, Wilkinson GR, Guengerich FP 1987 Hepatic metabolism of tolbutamide: characterization of the form of cytochrome P450 involved in the methyl hydroxylation and relationship to in vivo disposition. J Pharmacol Exp Ther 241:1112-1119
25. Baldwin SJ, Bloomer JC, Smith GJ, Ayrton AD, Clarke SE, Chenery RJ 1995 Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9. Xenobiotica 25:261-270
26. Yasumori T, Nagata K, Yang SK, Chen LS, Murayama N, Yamazoe Y, Kato R 1993 Cytochrome P450 mediated metabolism of diazepam in human and rat: involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner. Pharmacogenetics 3:291-301
27. Lacroix D, Sonnier M, Moncion A, Cheron G, Cresteil T 1997 Expression of CYP3A in the human liver: evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 247:625-634
28. Treluyer JM, Gueret G, Cheron G, Sonnier M, Cresteil T 1997 Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in vivo/in vitro correlation and inducibility. Pharmacogenetics 7:441-452
29. Zeldin DC, Moomaw CR, Jesse N, Tomer KB, Beetham J, Hammock BD, Wu S 1996 Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway. Arch Biochem Biophys 330:87-96
30. Sonnier M, Cresteil T 1998 Delayed ontogeny of CYP1A2 in the human liver. Eur J Biochem 251:893-898
31. 2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol 264:H327-335
32. Zeldin DC, Plitman JD, Kobayashi J, Miller RF, Snapper JR, Falck JR, Szarek JL, Philpot RM, Capdevila JH 1995 The rabbit pulmonary cytochrome P450 arachidonic acid metabolic pathway: characterization and significance. J Clin Invest 95:2150-2160
33. Proctor KG, Falck JR, Capdevila J 1987 Intestinal vasodilatation by epoxyeicosatrienoic acids: arachidonic acid metabolites produced by a cytochrome P450 monooxygenase. Circ Res 60:50-59
34. Gebremedhin D, Ma YH, Falck JR, Roman RJ, VanRollins M, Harder DR 1992 Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Physiol 263:H519-525
35. Bysani GK, Kennedy TP, Ky N, Rao NV, Blaze CA, Hoidel JR 1990 Role of cytochrome P450 in reperfusion injury of the rabbit lung. J Clin Invest 86:1434-1441
36. Moffat MP, Ward CA, Bend JR, Mock T, Farhangkhoee P, Karmazyn M 1993 Effects of epoxyeicosatrienoic acids on isolated hearts and ventricular myocytes. Am J Physiol 264:H1154-1160